DK3898946T3 - Mukosa-associerede invariante t- (mait) celler med ekspression af kimære antigenreceptorer - Google Patents

Mukosa-associerede invariante t- (mait) celler med ekspression af kimære antigenreceptorer Download PDF

Info

Publication number
DK3898946T3
DK3898946T3 DK19824315.6T DK19824315T DK3898946T3 DK 3898946 T3 DK3898946 T3 DK 3898946T3 DK 19824315 T DK19824315 T DK 19824315T DK 3898946 T3 DK3898946 T3 DK 3898946T3
Authority
DK
Denmark
Prior art keywords
mait
mucosa
cells expressing
chimeric antigen
antigen receptors
Prior art date
Application number
DK19824315.6T
Other languages
English (en)
Inventor
Sophie Caillat-Zucman
Olivier Lantz
Original Assignee
Inst Nat Sante Rech Med
Inst Curie
Univ Paris Cite
Assist Publique Hopitaux Paris Aphp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Inst Curie, Univ Paris Cite, Assist Publique Hopitaux Paris Aphp filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK3898946T3 publication Critical patent/DK3898946T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4631—Chimeric Antigen Receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19824315.6T 2018-12-19 2019-12-18 Mukosa-associerede invariante t- (mait) celler med ekspression af kimære antigenreceptorer DK3898946T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306743 2018-12-19
PCT/EP2019/085998 WO2020127513A1 (en) 2018-12-19 2019-12-18 Mucosal-associated invariant t (mait) cells expressing chimeric antigen receptors

Publications (1)

Publication Number Publication Date
DK3898946T3 true DK3898946T3 (da) 2023-05-01

Family

ID=65279386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19824315.6T DK3898946T3 (da) 2018-12-19 2019-12-18 Mukosa-associerede invariante t- (mait) celler med ekspression af kimære antigenreceptorer

Country Status (9)

Country Link
US (1) US20220016171A1 (da)
EP (2) EP3898946B1 (da)
JP (2) JP7429882B2 (da)
KR (1) KR20210138565A (da)
CN (1) CN113286875A (da)
DK (1) DK3898946T3 (da)
ES (1) ES2944062T3 (da)
PT (1) PT3898946T (da)
WO (1) WO2020127513A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022122961A1 (en) * 2020-12-10 2022-06-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mait cells for controlling graft versus host disease
GB202105684D0 (en) * 2021-04-21 2021-06-02 Imperial College Innovations Ltd Chimeric antigen receptor (CAR)-T cells
GB202105682D0 (en) * 2021-04-21 2021-06-02 Imp College Innovations Ltd Chimeric antigen receptor (CAR)-T cells
GB202105686D0 (en) * 2021-04-21 2021-06-02 Imperial College Innovations Ltd Chimeric antigen receptor (CAR)-T cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2961498T3 (es) 2008-08-26 2024-03-12 Hope City Método y composiciones para el funcionamiento mejorado del efecto antitumoral de las células T
WO2014031687A1 (en) 2012-08-20 2014-02-27 Jensen, Michael Method and compositions for cellular immunotherapy
US20150353889A1 (en) * 2012-10-30 2015-12-10 Daiichi Sankyo Company, Limited Mait-like Cells and Method for Manufacturing Same
TWI654206B (zh) 2013-03-16 2019-03-21 諾華公司 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症
EP3593812A3 (en) * 2014-03-15 2020-05-27 Novartis AG Treatment of cancer using chimeric antigen receptor

Also Published As

Publication number Publication date
EP4219688A1 (en) 2023-08-02
ES2944062T3 (es) 2023-06-19
PT3898946T (pt) 2023-05-09
EP3898946B1 (en) 2023-02-08
EP3898946A1 (en) 2021-10-27
JP7429882B2 (ja) 2024-02-09
CN113286875A (zh) 2021-08-20
KR20210138565A (ko) 2021-11-19
JP2024045239A (ja) 2024-04-02
JP2022519436A (ja) 2022-03-24
WO2020127513A1 (en) 2020-06-25
US20220016171A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
DK3898946T3 (da) Mukosa-associerede invariante t- (mait) celler med ekspression af kimære antigenreceptorer
DK3642224T3 (da) T-cellereceptorer
SG11202101825QA (en) Methods of making chimeric antigen receptor-expressing cells
DK3448882T3 (da) Anti-kk-lc-1-t-cellereceptorer
IL277414A (en) NK-92 cells with chimeric antigen receptor modification
BR112018004981A2 (pt) anticorpos anti-pró-miostatina/miostatina latente e usos destes.
DK3198742T3 (da) Netværksknude, brugerindretning og fremgangsmåder deri for at gøre det muligt for brugerindretningen at bestemme en forkoderkodebog
DK3886226T3 (da) Batteripakke
BR112016011567A2 (pt) receptores de célula t humana de alta afinidade geneticamente modificados.
DK3561921T3 (da) Lithiumion-sekundærbatteri
DK3529611T3 (da) Fremgangsmåder til screening af b-cellelymfocytter
ES2969689T3 (es) Batería secundaria
DK3490372T3 (da) Indretning til opdræt af akvakulturdyr til søs
DK3362470T3 (da) Kimære antigenreceptorer indeholdende et chlorotoxindomæne
DE112017001979A5 (de) Ersatzschaltbildbasiertes Brennstoffzellen-Prognosemodell
ES2969105T3 (es) Cartucho de revelador
IL280849A (en) Photovoltaic cells are color sensitive
DE102020112518B8 (de) Toner
MA55911A (fr) Lymphocytes t génétiquement modifiés
JP1656715S (ja) 充電器
DE102016011684B8 (de) Galvanisches Element
DE112019005840A5 (de) Batteriezelle
DK3660614T3 (da) Undtagelsesbaseret ruteplangenerering
TWI799569B (zh) 固體電解質接合體
DE112019003347A5 (de) Trennvorrichtung